| A nationwide analysis of risk of prostate cancer diagnosis and mortality following an initial negative transrectal ultrasound biopsy with long-term followup SM Kawa, HV Stroomberg, SB Larsen, JT Helgstrand, BG Toft, AJ Vickers, ... The Journal of urology 208 (1), 100-108, 2022 | 20 | 2022 |
| Non‐apical positive surgical margins after radical prostatectomy for pT2 prostate cancer is associated with the highest risk of recurrence MA Røder, S Kawa, T Scheike, BG Toft, JB Hansen, K Brasso, B Vainer, ... Journal of Surgical Oncology 109 (8), 818-822, 2014 | 7 | 2014 |
| What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review SM Kawa, SB Larsen, JT Helgstrand, P Iversen, K Brasso, MA Røder BMJ open 10 (12), e040965, 2020 | 5 | 2020 |
| Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period SM Kawa, HV Stroomberg, SB Larsen, JT Helgstrand, BG Toft, K Brasso, ... Urology, 2021 | 3 | 2021 |
| Prostate biopsies-strategy and value of negative biopsies SM Kawa University of Copenhagen, 2022 | | 2022 |
| Changes in Gleason score misclassification between diagnostic biopsies and radical prostatectomy specimens–a nationwide analysis JT Helgstrand, MA Røder, N Klemann, SM Kawa, BG Toft, K Brasso European Urology Supplements 18 (1), e209-e210, 2019 | | 2019 |
| Location of iatrogenic positive surgical margins after radical prostatectomy for localized prostate cancer is associated with the risk of biochemical recurrence. MA Røder, SM Kawa, T Scheike, BG Toft, J Hansen, K Brasso, B Vainer, ... Urology 82 (3), 2013 | | 2013 |
| Does the location of pt2 positive surgical margins influence the risk of biochemical recurrence after radical prostatectomy for localized prostate cancer? MA Røder, S Kawa, T Scheike, BG Toft, JB Hansen, K Brasso, B Vainer, ... Scandinavian Journal of Urology 47 (A67), 2013 | | 2013 |
| The ability of systematic TRUS-biopsies to detect clinically significant prostate cancer stratified by age, clinical tumor category and PSA in the Danish population. SM Kawa | | |
Andreas RøderCopenhagen Prostate Cancer CenterVerified email at regionh.dk
